Zurich, Switzerland

Beat Fluehmann


Average Co-Inventor Count = 2.7

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2004-2007

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Beat Fluehmann: Innovator in Diabetes Treatment

Introduction

Beat Fluehmann is a notable inventor based in Zurich, Switzerland. He has made significant contributions to the field of diabetes treatment, particularly focusing on non-insulin dependent diabetes mellitus. With a total of 2 patents, his work has the potential to impact many lives.

Latest Patents

Fluehmann's latest patents include a method of treating non-insulin dependent diabetes mellitus with phytanic acid derivatives. This invention outlines a method for the treatment or prevention of Type II diabetes mellitus and related conditions such as obesity. The patent details the use of phytanic acid derivatives for this purpose. Additionally, he has developed a method for making a composition that combines phytanic acid or its derivatives with a pharmaceutically acceptable additive or adjuvant. This composition aims to treat or prevent non-insulin dependent diabetes mellitus effectively.

Career Highlights

Throughout his career, Beat Fluehmann has worked with prominent companies in the nutritional and pharmaceutical sectors. Notable among these are Roche Vitamins Inc. and Dsm Nutritional Products Inc. His experience in these organizations has contributed to his expertise in developing innovative treatments for diabetes.

Collaborations

Fluehmann has collaborated with several professionals in his field, including Willi Hunziker and Manuel Heim. These partnerships have likely enhanced his research and development efforts, leading to his successful patent applications.

Conclusion

Beat Fluehmann's contributions to diabetes treatment through his innovative patents demonstrate his commitment to improving health outcomes. His work with phytanic acid derivatives represents a significant advancement in the management of non-insulin dependent diabetes mellitus.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…